🇺🇸 TACRINE HYDROCHLORIDE in United States

47 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 10 reports (21.28%)
  2. No Adverse Event — 10 reports (21.28%)
  3. Off Label Use — 10 reports (21.28%)
  4. Cough — 3 reports (6.38%)
  5. Pneumonia — 3 reports (6.38%)
  6. Pyrexia — 3 reports (6.38%)
  7. Adjustment Disorder — 2 reports (4.26%)
  8. Affect Lability — 2 reports (4.26%)
  9. Angina Pectoris — 2 reports (4.26%)
  10. Anxiety — 2 reports (4.26%)

Source database →

TACRINE HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TACRINE HYDROCHLORIDE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for TACRINE HYDROCHLORIDE in United States?

Marketing authorisation holder not available in our data.